Central Nervous System Insomnia or Sleep Disorders

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Nov 2014

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Agennix AG (Symbol:AGX) SWOT Analysis, Strategy, Revenues and Profits

Agennix AG (Symbol:AGX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Agennix AG SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: Germany, United States

Astralis, Ltd. SWOT Analysis, Strategy, Revenues and Profits

Astralis, Ltd. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: United States

Canadian Diabetes Association SWOT Analysis, Strategy, Revenues and Profits

Canadian Diabetes Association SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: Canada

GenMont Biotech Inc. (Symbol:3164) SWOT Analysis, Strategy, Revenues and Profits

GenMont Biotech Inc. (Symbol:3164) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. GenMont Biotech Inc. SWOT Analysis report provides you a strategic ...

Industries: Pathology

GlaxoSmithKline S.A.E. (Symbol:BIOC) SWOT Analysis, Strategy, Revenues and Profits

GlaxoSmithKline S.A.E. (Symbol:BIOC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. GlaxoSmithKline S.A.E. SWOT Analysis report provides you a strategic ...

Industries: Pathology | Countries: Egypt

Henan Lingrui Pharmaceutical Co., Ltd. (Symbol:600285) SWOT Analysis, Strategy, Revenues and Profits

Henan Lingrui Pharmaceutical Co., Ltd. (Symbol:600285) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Henan Lingrui Pharmaceutical Co., Ltd. SWOT Analysis report provides ...

Industries: Pathology

Herborium Group, Inc. (HBRM) - Financial and Strategic SWOT Analysis Review

Herborium Group, Inc. (HBRM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary Herborium Group, Inc. (Herborium) is a botanical therapeutics company. The company develops, licenses, and markets botanical based medicinal products used for the treatment of unmet medical needs. Its products include acnease, lasting energy, for him and her, liver activator series, all botanical ...

Industries: Pathology | Countries: United States

IMMUNOSYN CORPORATION (Symbol:IMYN) SWOT Analysis, Strategy, Revenues and Profits

IMMUNOSYN CORPORATION (Symbol:IMYN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. IMMUNOSYN CORPORATION SWOT Analysis report provides you a strategic ...

Industries: Pathology | Countries: United States

Neurobiological Technologies, Inc. (Symbol:NTII) SWOT Analysis, Strategy, Revenues and Profits

Neurobiological Technologies, Inc. (Symbol:NTII) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Neurobiological Technologies, Inc. SWOT Analysis report provides you ...

Industries: Pathology | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.